References
- AlmazrooOAMiahMKVenkataramananRDrug metabolism in the liverClin Liver Dis201721112027842765
- MaierCLDuncanAHillCEPharmacogenetics in oral antithrombotic therapyClin Lab Med201636346147227514462
- ValdesRJrYinDTFundamentals of pharmacogenetics in personalized, precision medicineClin Lab Med201636344745927514461
- WeberWWPharmacogenetics: from description to predictionClin Lab Med200828449951119059058
- YasminaADeneerVHMaitland-van der ZeeAHvan StaaTPde BoerAKlungelOHApplication of routine electronic health record databases for pharmacogenetic researchJ Intern Med2014275659060424581153
- Fricke-GalindoICéspedes-GarroCRodrigues-SoaresFInterethnic variation of CYP2C19 alleles, ‘predicted’ phenotypes and ‘measured’ metabolic phenotypes across world populationsPharmacogenomics J201616211312326503820
- KorshunovaNKatsuyamaHDemuraMPosttraumatic stress disorders in the Nanai after pollution of the Amur River: ethnocultural analysisEnviron Health Prev Med201318648549323780747
- TangHQuertermousTRodriguezBGenetic structure, self-identified race/ethnicity, and confounding in case-control association studiesAm J Hum Genet200576226827515625622
- CaudleKERettieAEWhirl-CarrilloMClinical Pharmacogenetics Implementation Consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosingClin Pharmacol Ther201496554254825099164
- HicksJKBishopJRSangkuhlKClinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitorsClin Pharmacol Ther201598212713425974703
- RamseyLBJohnsonSGCaudleKEThe Clinical Pharmacogenetics Implementation Consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 updateClin Pharmacol Ther201496442342824918167
- Karaźniewicz-ŁadaMDanielakDRubiśBImpact of common ABCB1 polymorphism on pharmacokinetics and pharmacodynamics of clopidogrel and its metabolitesJ Clin Pharm Ther201540222623125430046
- ArnoldFLKusamaMOnoSExploring differences in drug doses between Japan and Western countriesClin Pharmacol Ther201087671472020410879
- VasilyevFFDanilovaDAKaimonovVSChertovskihYVMaksimovaNRFrequency distribution of polymorphisms of CYP2C19, CYP2C9, VKORC1 and SLCO1B1 genes in the Yakut populationRes Pharm Sci201611325926427499796
- SychevDAShuevGNChertovskihJVMaksimovaNRGrachevAVSyrkovaOAThe frequency of SLCO1B1*5 polymorphism genotypes among Russian and Sakha (Yakutia) patients with hypercholesterolemiaPharmgenomics Pers Med20169596327307760
- KorytinaGKochetovaOAkhmadishinaLViktorovaEVictorovaTPolymorphisms of cytochrome P450 genes in three ethnic groups from RussiaBalkan Med J201229325226025207010
- MustafinaOETuktarovaIAKarimovDDSomovaRSNasibullinTRCYP2D6, CYP3A5, and CYP3A4 gene polymorphism in Russian, Tatar, and Bashkir populationsGenetika2015511109119 Russian25857198
- DuzhakTMitrofanovDOstashevskiiVGenetic polymorphisms of CYP2D6, CYP1A1, GSTM1 and p53 genes in a unique Siberian population of tundra NentsiPharmacogenetics200010653153710975607
- Céspedes-GarroCFricke-GalindoINaranjoMEWorldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypesExpert Opin Drug Metab Toxicol201511121893190526595139
- PharmGKBGene: CYP2C9 Available from: https://www.pharmgkb.org/gene/PA126Accessed March 9, 2017
- PharmGKBGene: CYP2C19 Available from: https://www.pharmgkb.org/gene/PA124Accessed March 9, 2017
- LlerenaANaranjoMERodrigues-SoaresFPenas-LledóEMFariñasHTarazona-SantosEInterethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populationsExpert Opin Drug Metab Toxicol201410111569158325316321
- PharmGKBGene: CYP2D6 Available from: https://www.pharmgkb.org/gene/PA128Accessed March 9, 2017
- AmeyawMMRegateiroFLiTMDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicityPharmacogenetics200111321722111337937
- PasanenMKNeuvonenPJNiemiMGlobal analysis of genetic variation in SLCO1B1Pharmacogenomics200891193318154446
- PharmGKBGene: SLCO1B1 Available from: https://www.pharmgkb.org/gene/PA134865839Accessed March 9, 2017
- GaikovitchEACascorbiIMrozikiewiczPMPolymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian populationEur J Clin Pharmacol200359430331212879168
- GraOMityaevaOBerdichevetsIMicroarray-based detection of CYP1A1, CYP2C9, CYP2C19, CYP2D6, GSTT1, GSTM1, MTHFR, MTRR, NQO1, NAT2, HLA-DQA1, and AB0 allele frequencies in native RussiansGenet Test Mol Biomarkers201014332934220373852
- SychevDADenisenkoNPSizovaZMGrachevAVVelikolugKAThe frequency of CYP2C19 genetic polymorphisms in Russian patients with peptic ulcers treated with proton pump inhibitorsPharmgenomics Pers Med2015811111426109874